Silk Road Medical, Inc. (SILK)

NASDAQ: SILK · IEX Real-Time Price · USD
52.88
+0.28 (0.53%)
Dec 7, 2022 4:00 PM EST - Market closed
0.53%
Market Cap 2.04B
Revenue (ttm) 126.83M
Net Income (ttm) -57.28M
Shares Out 35.30M
EPS (ttm) -1.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 329,332
Open 52.36
Previous Close 52.6
Day's Range 52.36 - 54.26
52-Week Range 27.21 - 54.8
Beta 1.27
Analysts Buy
Price Target 48.96 (-7.4%)
Earnings Date Nov 8, 2022

About SILK

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid a... [Read more]

Industry Health Care Equipment & Supplies
IPO Date Apr 4, 2019
CEO Erica Rogers
Employees 352
Stock Exchange NASDAQ
Ticker Symbol SILK
Full Company Profile

Financial Performance

In 2021, SILK's revenue was $101.48 million, an increase of 34.89% compared to the previous year's $75.23 million. Losses were -$49.85 million, 5.33% more than in 2020.

Financial Statements

Analyst Forecast

According to 14 analysts, the average rating for SILK stock is "Buy." The 12-month stock price forecast is 48.96, which is a decrease of -7.41% from the latest price.

Price Target
$48.96
(-7.41% downside)
Analyst Consensus: Buy
Stock Forecasts

News

Silk Road Medical (SILK) is a Great Momentum Stock: Should You Buy?

Does Silk Road Medical (SILK) have what it takes to be a top stock pick for momentum investors? Let's find out.

2 days ago - Zacks Investment Research

Silk Road Medical (SILK) Reports Q3 Loss, Tops Revenue Estimates

Silk Road Medical (SILK) delivered earnings and revenue surprises of 34.09% and 10.44%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

4 weeks ago - Zacks Investment Research

Silk Road Medical to Present at Upcoming Investor Conferences

SUNNYVALE, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) --  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that management...

1 month ago - GlobeNewsWire

Silk Road Medical to Report Third Quarter 2022 Financial Results on November 8, 2022

SUNNYVALE, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report f...

1 month ago - GlobeNewsWire

Silk Road Medical (SILK) Stock Jumps 6.7%: Will It Continue to Soar?

Silk Road Medical (SILK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price incr...

1 month ago - Zacks Investment Research

Silk Road Medical Announces Pricing of Public Offering

SUNNYVALE, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the pricing of a...

1 month ago - GlobeNewsWire

Silk Road Medical Announces Certain Preliminary Financial Data For Quarter Ended September 30, 2022

SUNNYVALE, Calif., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced certain prelimin...

1 month ago - GlobeNewsWire

Silk Road Medical Announces Proposed Public Offering of Common Stock

SUNNYVALE, Calif., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, announced today the commencement...

1 month ago - GlobeNewsWire

Strength Seen in Silk Road Medical (SILK): Can Its 9.3% Jump Turn into More Strength?

Silk Road Medical (SILK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near t...

2 months ago - Zacks Investment Research

Silk Road Medical Announces First Patient Enrolled in ROADSTER 3 Post Approval Study Evaluating TCAR® System in the T...

SUNNYVALE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced enrollment of t...

3 months ago - GlobeNewsWire

Silk Road Medical to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

SUNNYVALE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will...

3 months ago - GlobeNewsWire

Silk Road Medical (SILK) Reports Q2 Loss, Tops Revenue Estimates

Silk Road Medical (SILK) delivered earnings and revenue surprises of 6.38% and 6.91%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Silk Road Medical Reports Second Quarter 2022 Financial Results

SUNNYVALE, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results...

4 months ago - GlobeNewsWire

Silk Road Medical to Report Second Quarter 2022 Financial Results on July 26, 2022

SUNNYVALE, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report f...

4 months ago - GlobeNewsWire

Silk Road Medical Announces Post Approval Study for the Treatment of Standard Surgical Risk Patients using TCAR

SUNNYVALE, Calif., June 15, 2022 (GLOBE NEWSWIRE) --  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced a prospective s...

5 months ago - GlobeNewsWire

Silk Road Medical Announces Expanded Medicare Coverage for TCAR in Standard Surgical Risk Patients

SUNNYVALE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that the Centers...

6 months ago - GlobeNewsWire

Silk Road Medical Extends Cash Runway by Securing up to $250 Million in Debt Financing

SUNNYVALE, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Company) (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it...

6 months ago - GlobeNewsWire

Silk Road Medical (SILK) Reports Q1 Loss, Tops Revenue Estimates

Silk Road Medical (SILK) delivered earnings and revenue surprises of -17.07% and 5.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

7 months ago - Zacks Investment Research

Silk Road Medical Reports First Quarter 2022 Financial Results

SUNNYVALE, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results ...

7 months ago - GlobeNewsWire

Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE® Transcarotid Stent System

SUNNYVALE, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that that the U.S...

7 months ago - GlobeNewsWire

Silk Road Medical to Present at the BofA Securities 2022 Healthcare Conference

SUNNYVALE, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company wil...

7 months ago - GlobeNewsWire

Silk Road Medical to Report First Quarter 2022 Financial Results on May 4, 2022

SUNNYVALE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report ...

7 months ago - GlobeNewsWire

Silk Road Unveils Kirkland Lake Exploration Plan

Calgary, Alberta--(Newsfile Corp. - April 13, 2022) - Silk Road Energy Inc. (TSXV: SLK.H) reports that it has finalized its 2022 exploration program for its 100 percent-owned Amikougami gold property in...

7 months ago - Newsfile Corp

Silk Road Medical (SILK) Reports Q4 Loss, Tops Revenue Estimates

Silk Road Medical (SILK) delivered earnings and revenue surprises of -5% and 8.75%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

Silk Road Medical Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Financial Outlook

SUNNYVALE, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results...

9 months ago - GlobeNewsWire